Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Add To Watchlist

TSX:SVA - Post Discussion

Sernova Corp > Treat 1% of 1.6M U.S. Diabetes 1 Patients

View:

Post by steadfast on Sep 08, 2022 3:07pm

Treat 1% of 1.6M U.S. Diabetes 1 Patients

x average price of $300,000 - 400,000 per patient generates over $5Billion in Growth annually.
Phil said annually, however he also said pouch last for 2 yr period. Altho #1Patient is still
fine after 2 1/2 years. Thus each year treat 1% of the 1.6M . The Health Insce companies have taken into consideratoin with this high price tag,they will not have to spend to treat the cost of side effects once the patient is cured of diabetes.

263

Comment

Comment by BioTeck on Sep 08, 2022 3:22pm

This info has been published many many moons ago by SVA and brought up in nearly every presentation since. Google Sernova Payor survey if you don't believe me. Nothing in that presentation was new except patient 7 selected and due for implant of larger pouch in mid october. Results not expected till mid next year assuming they actually hit the timelines. THey've been talking about ...more

237

Comment

Comment by Metalsguy1 on Sep 09, 2022 10:35am

steadfast it sounds like we will be eating the dust of the competition long before we ever see a product by Sernova hit the market. Watching a Bingo game at an old folks home is more riveting than watching management at Sernova.

222

Comment